CTMX

CytomX Therapeutics, Inc.

SEC CIK 1501989
$3.31 −38.9% · 90 days
90-day buys
$0
0 open-market
90-day sells
$5K
1 open-market
Net insider flow
−$5K
Net selling
Filings shown
9
Most recent
Revenue (FY2025)
$76.2M
−44.8% YoY
Net income (FY2025)
−$17.37M
Reported
Total assets
$151.57M
Balance sheet
Source
SEC XBRL
From 10-K/10-Q
Advertisement

At a glance

Over the last 90 days, insiders at CTMX have sold a net $5K of stock (0 open-market buys vs 1 sell).

Largest recent trade: Ogden Christopher sold $124.1K of CTMX, trimming their stake 6%.

Most active filer: Ogden Christopher, with 9 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for CTMX, newest first
View on SEC EDGAR ↗
CTMX
Sell Ogden Christopher · Chief Financial Officer · Open-market sale · filed 1w ago ΔOwn −0.5%

Ogden Christopher sold $5K of CTMX, trimming their stake 1%.

−$5K
1,624 sh @ $3
CTMX
Sell Ogden Christopher · Chief Financial Officer · Open-market sale · filed Mar 19, 2026 ΔOwn −6.1%

Ogden Christopher sold $124.1K of CTMX, trimming their stake 6%.

−$124.1K
19,323 sh @ $6
CTMX
Sell Ogden Christopher · Chief Financial Officer · Open-market sale · filed Jun 17, 2025 ΔOwn −4.5%

Ogden Christopher sold $28.5K of CTMX, trimming their stake 4%.

−$28.5K
10,614 sh @ $3
CTMX
Sell Ogden Christopher · Chief Financial Officer · Open-market sale · filed Jun 17, 2025 ΔOwn −0.8%

Ogden Christopher sold $4.8K of CTMX, trimming their stake 1%.

−$4.8K
1,641 sh @ $3
CTMX
Sell Ogden Christopher · Chief Financial Officer · Open-market sale · filed Mar 20, 2025 ΔOwn −4.1%

Ogden Christopher sold $5.1K of CTMX, trimming their stake 4%.

−$5.1K
8,551 sh @ $1
Advertisement
CTMX
Sell Ogden Christopher · Chief Financial Officer · Open-market sale · filed Aug 22, 2024 ΔOwn −1.8%

Ogden Christopher sold $2.4K of CTMX, trimming their stake 2%.

−$2.4K
1,984 sh @ $1
CTMX
Sell Ogden Christopher · SVP, Finance and Accounting · Open-market sale · filed Mar 21, 2024 ΔOwn −3.4%

Ogden Christopher sold $6.2K of CTMX, trimming their stake 3%.

−$6.2K
2,971 sh @ $2
CTMX
Sell Ogden Christopher · SVP, Finance and Accounting · Open-market sale · filed Dec 22, 2023 ΔOwn −3.9%

Ogden Christopher sold $2.7K of CTMX, trimming their stake 4%.

−$2.7K
1,990 sh @ $1
CTMX
Sell Ogden Christopher · SVP, Finance and Accounting · Open-market sale · filed Mar 20, 2023 ΔOwn −1.3%

Ogden Christopher sold $1K of CTMX, trimming their stake 1%.

−$1K
516 sh @ $2
Advertisement

About CTMX insider activity

This page tracks every recent Form 4 filed for CytomX Therapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is CTMX insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for CytomX Therapeutics, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.